scPharmaceuticals Statistics
Total Valuation
SCPH has a market cap or net worth of $164.41 million. The enterprise value is $128.66 million.
| Market Cap | 164.41M |
| Enterprise Value | 128.66M |
Important Dates
The next estimated earnings date is Wednesday, May 8, 2024, after market close.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SCPH has 36.05 million shares outstanding. The number of shares has increased by 35.81% in one year.
| Shares Outstanding | 36.05M |
| Shares Change (YoY) | +35.81% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 6.59% |
| Owned by Institutions (%) | 75.90% |
| Float | 18.32M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.10 |
| Forward PS | 4.03 |
| PB Ratio | 4.42 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.08, with a Debt / Equity ratio of 1.08.
| Current Ratio | 7.08 |
| Quick Ratio | 6.13 |
| Debt / Equity | 1.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.75 |
Financial Efficiency
Return on equity (ROE) is -97.20% and return on invested capital (ROIC) is -71.49%.
| Return on Equity (ROE) | -97.20% |
| Return on Assets (ROA) | -49.60% |
| Return on Capital (ROIC) | -71.49% |
| Revenue Per Employee | $100,689 |
| Profits Per Employee | -$406,000 |
| Employee Count | 135 |
| Asset Turnover | 0.12 |
| Inventory Turnover | 0.76 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.52% in the last 52 weeks. The beta is 0.05, so SCPH's price volatility has been lower than the market average.
| Beta (1Y) | 0.05 |
| 52-Week Price Change | -53.52% |
| 50-Day Moving Average | 5.34 |
| 200-Day Moving Average | 6.26 |
| Relative Strength Index (RSI) | 39.38 |
| Average Volume (30 Days) | 229,262 |
Short Selling Information
The latest short interest is 4.62 million, so 12.80% of the outstanding shares have been sold short.
| Short Interest | 4.62M |
| Short Previous Month | 4.65M |
| Short % of Shares Out | 12.80% |
| Short % of Float | 25.20% |
| Short Ratio (days to cover) | 16.78 |
Income Statement
In the last 12 months, SCPH had revenue of $13.59 million and -$54.81 million in losses. Loss per share was -$1.42.
| Revenue | 13.59M |
| Gross Profit | 9.78M |
| Operating Income | -55.40M |
| Pretax Income | -54.81M |
| Net Income | -54.81M |
| EBITDA | -46.06M |
| EBIT | -46.69M |
| Loss Per Share | -$1.42 |
Balance Sheet
The company has $76.01 million in cash and $40.27 million in debt, giving a net cash position of $35.74 million or $0.99 per share.
| Cash & Cash Equivalents | 76.01M |
| Total Debt | 40.27M |
| Net Cash | 35.74M |
| Net Cash Per Share | $0.99 |
| Equity / Book Value | 37.22M |
| Book Value Per Share | 1.03 |
| Working Capital | 79.80M |
Cash Flow
In the last 12 months, operating cash flow was -$59.24 million and capital expenditures -$40,000, giving a free cash flow of -$59.28 million.
| Operating Cash Flow | -59.24M |
| Capital Expenditures | -40,000 |
| Free Cash Flow | -59.28M |
| FCF Per Share | -$1.54 |
Margins
Gross margin is 71.96%, with operating and profit margins of -407.53% and -403.22%.
| Gross Margin | 71.96% |
| Operating Margin | -407.53% |
| Pretax Margin | -403.22% |
| Profit Margin | -403.22% |
| EBITDA Margin | -338.86% |
| EBIT Margin | -343.46% |
| FCF Margin | -436.14% |
Dividends & Yields
SCPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -35.81% |
| Shareholder Yield | -35.81% |
| Earnings Yield | -33.34% |
| FCF Yield | -36.06% |
Analyst Forecast
The average price target for SCPH is $19.33, which is 323.90% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.33 |
| Price Target Difference | 323.90% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 89.75% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SCPH has an Altman Z-Score of -2.92. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.92 |
| Piotroski F-Score | n/a |